MedTrace Logo

Comparison of Post-Discharge Growth of Premature Infants Using Two Different Formulas

NCT01759134 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2013-10-25

No results posted yet for this study

Summary

The objective of this study is to compare the post-discharge growth of preterm infants fed with 2 different post discharge formulas.

Conditions

  • Premature Birth of Newborn

Interventions

OTHER

Post discharge formula

Babies will be given either materna sensitive or similac neosure

Sponsors & Collaborators

  • Shaare Zedek Medical Center

    lead OTHER

Principal Investigators

  • Alona Bin-Nun, MD · Shaare Zedek Medical Center

  • Cathy Hammerman, MD · Shaare Zedek Medical Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Weeks
Max Age
34 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-01-31
Completion
2014-06-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01759134 on ClinicalTrials.gov